Literature DB >> 2856929

Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.

A Fischer, F Le Deist, A Durandy, C Griscelli.   

Abstract

Prostaglandin E2 (PGE2) is a potent inhibitor of immune functions. Two possible mechanisms of PGE2-mediated suppression have been proposed: one is a direct inhibitory effect exerted on interleukin 2-producing T cells; the second is mediated by the activation of nonspecific suppressor T lymphocytes. We previously showed that PGE2 can directly activate human T lymphocytes to suppress lymphocyte proliferation and B lymphocyte maturation. Herein is described the binding of 10 to 30% of human peripheral blood T lymphocytes to insolubilized PGE2 coated to albumin-Sepharose. The T lymphocytes that bound PGE2 (PGE2(+] could be eluted by the addition of serum and gentle shaking of the beads. The following data indicated the specificity of the binding: i) T lymphocytes after an overnight incubation, a condition known to abolish sensitivity to PGE2, lost their affinity for PGE2; ii) preincubation of T lymphocytes with PGE2 blocked the binding; iii) PGE2(+) T cells bound PGE after a 24-hr incubation, whereas PGE2(-) T cells did not. Few T cells bound albumin, and only a small percentage (7 to 9%) bound 6-keto-prostaglandin F1 alpha-coated beads. Among PGE2(+) T cells, there was a slight increase in the percentage of OKT8+ cells. Although T cells that had no affinity for PGE2 (PGE2(-] proliferated as well as unseparated T lymphocytes when stimulated with mitogens or antigens, the proliferative response of the PGE2(+) subset was poor. Moreover, PGE2(+) T lymphocytes did exert a strong suppressor activity on mitogen- or allogeneic cell-induced lymphocyte proliferation as well as on pokeweed mitogen-driven B cell maturation into Ig-containing cells. PGE2(-) T lymphocytes were shown not to exert a significant suppressor activity in these assays. The PGE2(+) subset-mediated suppression was not secondary to a carry-over of PGE2 released from the beads, because its suppressor activity was not altered by the addition of an anti-PGE2 serum. Moreover, PGE2(-) T lymphocytes were not sensitive to the inhibitory activity on cell proliferation of PGE2. These results indicate that a given functional subset of peripheral blood T lymphocytes binds PGE2, and that at least some of them are activated into suppressor T cells. The relationship between the PGE2-activatable T suppressor subset and other functionally defined suppressor T cells remains to be clarified; it is suggested, however, that PGE2 can act as an immunoregulator through the activation of identifiable suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856929

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).

Authors:  G de Saint-Basile; F Le Deist; J P de Villartay; N Cerf-Bensussan; O Journet; N Brousse; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

2.  Effects of naproxen on the hypobaric hypoxia-induced immune changes in male rats.

Authors:  Ananda Raj Goswami; Nilotpal Mandal; Goutam Dutta; Tusharkanti Ghosh
Journal:  Eur J Appl Physiol       Date:  2012-01-21       Impact factor: 3.078

3.  Suppressor-cell dysfunction in children with histiocytosis-X.

Authors:  B T Shannon; W A Newton
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

4.  Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids.

Authors:  D Santoli; P D Phillips; T L Colt; R B Zurier
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  Genetic study of a new X-linked recessive immunodeficiency syndrome.

Authors:  G de Saint-Basile; F Le Deist; M Caniglia; Y Lebranchu; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.

Authors:  G De Saint-Basile; N Schlegel; M Caniglia; F Le Deist; C Kaplan; T Lecompte; F Piller; A Fischer; C Griscelli
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

7.  The role of prostaglandin E2 in immune suppression following injury.

Authors:  J T Grbic; J A Mannick; D B Gough; M L Rodrick
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

Review 8.  Treatment of atopic eczema with evening primrose oil: rationale and clinical results.

Authors:  M J Kerscher; H C Korting
Journal:  Clin Investig       Date:  1992-02

9.  Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets.

Authors:  Ping Jin; Ena Wang; Maurizio Provenzano; Sara Deola; Silvia Selleri; Jiaqiang Ren; Sonia Voiculescu; David Stroncek; Monica C Panelli; Francesco M Marincola
Journal:  J Transl Med       Date:  2006-06-28       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.